|
|
Primary Myelofibrosis
Alternate Names : Agnogenic Myeloid Metaplasia, Idiopathic Myelofibrosis, Myelofibrosis, Myeloid Metaplasia
Calling Your Health Care Provider
Call for an appointment with your health care provider if symptoms of this disorder develop. Uncontrolled bleeding, shortness of breath, jaundice, and progressive confusion are symptoms that indicate a need for urgent or emergency care.
Today's Top News Stories | | Early Elective C-Sections Produce Complications - Jan 07, 2009, 17:00 Babies delivered at 37 weeks have double the troubles of those born at 39 weeks.
| | Gene Governs Response to Leukemia Chemotherapy - Jan 07, 2009, 17:00 Acute lymphoblastic leukemia is most common pediatric cancer. | | Teen Birth Rate Up in 26 States in 2006 - Jan 07, 2009, 14:00 Highest rates in South, Southwest; lowest rates in Northeast, government reports. | | Clinical Trials Update: Jan. 7, 2009 - Jan 07, 2009, 09:58
- Hypertension (High Blood Pressure)
- Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
- Memory Loss
| | Study of Everest Climbers Questions Oxygen Use - Jan 07, 2009, 17:00 Whether low levels would work for ER patients with hypoxia remains unclear. |
|
Jump to another section
Definition Primary Myelofibrosis Overview, Causes, & Risk Factors Primary Myelofibrosis Symptoms & Signs Primary Myelofibrosis Prevention Primary Myelofibrosis Diagnosis & Tests Primary Myelofibrosis Treatment Primary Myelofibrosis Prognosis Primary Myelofibrosis Complications Calling Your Health Care Provider
Topics that might be of interest to you Diseases & Conditions
Acute Myelogenous Leukemia (AML) - Adult Anemia
Tests & Exams
Bone Marrow Biopsy CBC Erythropoietin Platelet Count RBC Count WBC Count
Surgery & Procedures
Spleen Removal
Other Topics
Bleeding Into the Skin Bone Pain or Tenderness Breathing Difficulty Chemotherapy Gas/Flatus - Excessive Hepatomegaly Jaundice - Yellow Skin Paleness Splenomegaly
Review Date : 7/31/2003
Reviewed By : Corey Cutler, M.D., M.P.H., F.R.C.P.C., Department of Medical Oncology, Dana-Farber Cancer Institute; Instructor of Medicine, Harvard University, Boston, MA. Review provided by VeriMed Healthcare Network.
|
|